Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Colorectal Cancer
100%
Adenomatous Polyps
100%
Dietary Calcium
100%
Calcium Supplementation
100%
Colon Cancer
50%
Odds Ratio
33%
Confidence Interval
33%
Cochrane
33%
Adenoma
33%
Colorectal Adenomatous Polyps
33%
High Risk
16%
Randomized Controlled Trial
16%
Family History
16%
Protective Behavior
16%
Inflammatory Bowel Disease
16%
Patient numbers
16%
Developed Countries
16%
Colon
16%
MEDLINE
16%
Long Follow-up
16%
Dropout
16%
Intervention Studies
16%
Healthy Adults
16%
Increased Incidence
16%
Randomized Placebo-controlled Trial
16%
Adverse Events
16%
Dietary Factors
16%
Exclusion Criteria
16%
Sufficient Evidence
16%
Epidemiological Evidence
16%
Embase
16%
Fixed Effects Model
16%
Adenomatous Polyposis Coli
16%
Review Literature
16%
Dietary Calcium Intake
16%
Colorectal Adenoma
16%
Trial Quality
16%
Surrogate Endpoint
16%
Calcium Supplements
16%
Extracted Data
16%
Loss-to-follow-up
16%
Medicine and Dentistry
Supplementation
100%
Calcium Intake
100%
Colorectal Carcinoma
100%
Tubular Adenoma
100%
Isotopes of Calcium
50%
Colon Carcinoma
50%
Recurrent Disease
33%
Randomized Controlled Trial
33%
Adenoma
33%
Odds Ratio
33%
Colon
16%
Intervention Study
16%
Family History
16%
Systematic Review
16%
Inflammatory Bowel Disease
16%
Calcium Supplement
16%
Colorectal Adenoma
16%
Familial Adenomatous Polyposis
16%
Placebo
16%
Adverse Event
16%
Nursing and Health Professions
Adenomatous Polyp
100%
Supplementation
100%
Calcium Intake
100%
Colorectal Carcinoma
100%
Colon Carcinoma
50%
Odds Ratio
33%
Recurrent Disease
33%
Confidence Interval
33%
Adenoma
33%
Systematic Review
16%
Embase
16%
Cochrane Library
16%
Literature Review
16%
Placebo
16%
Adverse Event
16%
Family History
16%
Inflammatory Bowel Disease
16%
Colorectal Adenoma
16%
Familial Adenomatous Polyposis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adenomatous Polyp
100%
Colorectal Carcinoma
100%
Colon Carcinoma
50%
Randomized Controlled Trial
33%
Recurrent Disease
33%
Adenoma
33%
Normal Human
16%
Intervention Study
16%
Placebo
16%
Inflammatory Bowel Disease
16%
Adverse Event
16%
Calcium Supplement
16%
Colorectal Adenoma
16%
Familial Adenomatous Polyposis
16%